The fight against cancer is one of the major focus areas in the global biotech industry. We have invited some of the leading Nordic companies in this field to give updates on their priorities, challenges, and expected progress during 2023.

 

The event will include an introduction to the theme by Redeye analysts Richard Ramanius and Christian Binder, giving an overview of the oncology landscape, key trends as well as commercial and regulatory activity.

 

Apart from individual company presentations the event includes Q&A-sessions with each company as well as panel discussions.